#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	22286	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2035	1079.4	0	.	n	.	0	C451T	SNP	451	451	C	682	682	T	1315	T,C	961,330	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	22286	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2035	1079.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	1213	C,A	1180,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	41442	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3284	1241.0	0	.	n	.	0	T695C	SNP	695	695	T	900	900	C	1322	C,T,G	1255,24,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	41442	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3284	1241.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2176	2176	C	1277	C,G	1233,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	41442	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3284	1241.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2250	2250	A	1243	A	1211	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	41442	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3284	1241.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2802	2802	C	1235	C,T	1191,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	41442	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3284	1241.0	0	HET	.	.	.	C539T	.	539	539	C	744	744	C	1369	C,T	998,309	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	2338	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1490	155.2	0	.	p	.	0	M180T	NONSYN	538	540	ATG	881	883	ACG	213;213;213	A;C;G	203;207;209	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2860	folP	855	855	100.0	folP.l15.c4.ctg.1	1727	164.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1110	1112	AGC	288;292;295	A;G;C	276;283;282	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	252.1	1	SNP	p	S91F	1	.	.	271	273	TTC	586	588	TTC	281;280;284	T;T;C	271;273;276	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	252.1	1	SNP	p	G95N	0	.	.	283	285	GGC	598	600	GGC	274;273;272	G,A;G,A;C	265,1;264,1;266	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	252.1	1	SNP	p	D95G	1	.	.	283	285	GGC	598	600	GGC	274;273;272	G,A;G,A;C	265,1;264,1;266	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2702	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1266	210.7	1	SNP	p	G45D	0	.	.	133	135	GGC	454	456	GGC	363;362;361	G,A;G,A;C	352,1;350,1;354	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1324	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	941	139.4	0	.	n	.	0	A197.	DEL	197	197	A	516	516	A	312	A	294	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7208	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2867	249.2	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	312;311;312	G,C;A;C	302,1;295;303	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7208	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2867	249.2	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	310;312;311	C,A;G;T,C	296,5;302;297,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7208	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2867	249.2	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	310;312;311	C,A;G;T,C	296,5;302;297,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7208	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2867	249.2	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	310;312;311	C,A;G;T,C	296,5;302;297,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7208	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2867	249.2	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	311;312;311	T;C,T;C	300;304,1;303	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6432	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2615	243.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	293;280;283	G,C;G,T;C,A	280,1;270,1;272,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1191	1193	GCC	390;389;390	G;C;C,A,G	376;373;366,9,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1194	1196	ATG	388;388;386	A;T;G,C	374;375;363,9	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1206	1208	ACC	388;388;392	A,G;C,T;C,G	366,6;376,6;374,6	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1206	1208	ACC	388;388;392	A,G;C,T;C,G	366,6;376,6;374,6	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1707	1709	ACC	309;305;308	ACC,AC;C;C	297,1;296;300	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1761	1763	GCG	306;302;299	G;C;G	300;297;294	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1761	1763	GCG	306;302;299	G;C;G	300;297;294	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1884	1886	GGT	245;242;240	G,T;G;T,C	234,1;234;226,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1893	1895	AGC	235;236;233	A,G;G;C,G	220,4;229;222,2	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6478	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2332	272.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1911	1913	CCG	197;195;194	C,G;C,G;G	175,6;174,1;161	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	8566	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3093	274.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	293;294;288	C,G;C,T;G	267,1;282,2;270	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3672	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1768	205.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	578	578	C	230	C	215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	0	.	p	.	0	G210R	NONSYN	628	630	GGA	918	920	AGA	330;330;333	A;G,A;A,G	317;308,1;319,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	939	941	GGT	345;344;341	G,A;G;T,C	326,12;340;317,12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1044	1046	GAA	336;335;337	G;A,G;A	326;318,10;330	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	359;359;361	A,G,C;A,G,T;G,C,A	334,5,2;344,5,1;337,4,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	362;362;369	A,G;A,C;C,A	344,5;348,5;344,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4366	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1565	275.0	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	362;362;369	A,G;A,C;C,A	344,5;348,5;344,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	15176	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4855	309.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1704	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	977	172.3	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	314;319;318	A;T;G	305;308;309	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
